Fred Lublin, MD

Articles

Generational Perspective in Multiple Sclerosis Care

Stephen Krieger, MD;Rachel Brandstadter, MD;Fred Lublin, MD

June 23rd 2023

Dr Krieger, Dr Brandstadter, and Dr Lublin discuss the advances made in recognizing and managing multiple sclerosis over the last few decades and the challenges that remain.

Generational Perspectives in Multiple Sclerosis Care

Stephen Krieger, MD;Rachel Brandstadter, MD;Fred Lublin, MD

June 14th 2023

Dr Krieger, Dr Brandstadter, and Dr Lublin discuss the advances made in recognizing and managing multiple sclerosis over the last few decades and the challenges that remain.

The Future of Managing Multiple Sclerosis

Fred Lublin, MD;Patricia K. Coyle, MD;Scott Newsome, DO, MSCS, FAAN;Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC

February 2nd 2021

Fumarates for Treatment of RMS

Fred Lublin, MD;Patricia K. Coyle, MD;Scott Newsome, DO, MSCS, FAAN;Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC

January 26th 2021

S1P Receptor Modulators for Treatment of RMS

Fred Lublin, MD;Patricia K. Coyle, MD;Scott Newsome, DO, MSCS, FAAN;Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC

January 21st 2021

Cladribine for Treatment of RMS

Fred Lublin, MD;Patricia K. Coyle, MD;Scott Newsome, DO, MSCS, FAAN;Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC

January 20th 2021

Anti-CD20 Monoclonal Antibodies for Treatment of RMS

Fred Lublin, MD;Patricia K. Coyle, MD;Scott Newsome, DO, MSCS, FAAN;Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC

January 18th 2021

Strategies for Choosing Initial Therapy in MS

Fred Lublin, MD;Patricia K. Coyle, MD;Scott Newsome, DO, MSCS, FAAN;Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC

January 15th 2021

OPTIMUM Phase 3 Trial: Secondary End Point Effect on Fatigue

Fred Lublin, MD;Patricia K. Coyle, MD;Scott Newsome, DO, MSCS, FAAN;Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC

January 12th 2021

TRIUMPHANT-MS Trial: Fatigue in MS

Fred Lublin, MD;Patricia K. Coyle, MD;Scott Newsome, DO, MSCS, FAAN;Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC

January 5th 2021

Multiple Sclerosis Fatigue

Fred Lublin, MD;Patricia K. Coyle, MD;Scott Newsome, DO, MSCS, FAAN;Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC

January 4th 2021

QoL Issues in the Management of Multiple Sclerosis

Fred Lublin, MD;Patricia K. Coyle, MD;Scott Newsome, DO, MSCS, FAAN;Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC

January 1st 2021

Challenges in Optimally Treating Multiple Sclerosis

Fred Lublin, MD;Patricia K. Coyle, MD;Scott Newsome, DO, MSCS, FAAN;Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC

December 31st 2020

Cerebrospinal Fluid in Diagnosing Multiple Sclerosis

Fred Lublin, MD;Patricia K. Coyle, MD;Scott Newsome, DO, MSCS, FAAN;Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC

December 28th 2020

Misdiagnosis of Multiple Sclerosis

Fred Lublin, MD;Patricia K. Coyle, MD;Scott Newsome, DO, MSCS, FAAN;Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC

December 25th 2020

Use of MRI in Diagnosing Multiple Sclerosis

Fred Lublin, MD;Patricia K. Coyle, MD;Scott Newsome, DO, MSCS, FAAN;Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC

December 23rd 2020

2017 Changes to the McDonald Criteria: Diagnosing Multiple Sclerosis

Fred Lublin, MD;Patricia K. Coyle, MD;Scott Newsome, DO, MSCS, FAAN;Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC

December 16th 2020

Fred Lublin, MD: Current Challenges in MS

Fred Lublin, MD

March 11th 2019

The director of the Corinne Goldsmith Dickinson Center for MS at Mount Sinai School of Medicine spoke about the major issues in MS right now: being able to individually prognosticate, moving toward developing better therapies for a progressive disease, and repairing the damage to the nervous system.

Fred Lublin, MD: Beginning to Treat Progressive Multiple Sclerosis

Fred Lublin, MD

September 8th 2018

The MS expert discussed the field's recent foray into treating progressive forms of the disease and what is in development.

Fred Lublin, MD: The Primary Care Partnership in Multiple Sclerosis

Fred Lublin, MD

September 5th 2018

The director of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai Medical Center spoke about the relationship between primary care and specialists.

Fred Lublin, MD: The Need for Biomarkers in Multiple Sclerosis

Fred Lublin, MD

September 1st 2018

The Saunders Family Professor of Neurology and the director of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai Medical Center discussed the need for biomarkers in MS.